Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children - Randomized, Double Blind, Placebo Controlled Study

Next Previous
X
Search
Trial Profile

Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children - Randomized, Double Blind, Placebo Controlled Study

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Limosilactobacillus reuteri (Primary) ; Lactulose
  • Indications Abdominal pain; Constipation
  • Focus Therapeutic Use

    • Most Recent Events

    • 01 Dec 2020 Results of pooled data (n=101) from both RCTs (before and after interim analysis) assessing safety and efficacy of Lactobacillus reuteri DSM 17938 for the treatment of functional abdominal pain in children, published in the Clinical Nutrition.
    • 02 Oct 2012 Planned end date changed from 1 Feb 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov record.
    • 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top